Specific Diagnostics Announces the First Purchase Orders in Europe

October 4, 2021 – Mountain View, California – FOR IMMEDIATE RELEASE Specific Diagnostics today announced it has signed multi-year reagent rental agreements with two clinical microbiology laboratories in France, marking the commercialization of Specific’s transformative Reveal rapid AST instrument. T [...]

October 4th, 2021|News|

Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.

LAKEWOOD, Colo., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“we”, “us”, “our”, “Mesa” or the “Company”), a global leader in the design and manufacturing of critical quality control solutions for the pharmaceutical, healthcare, and medical device industries, announced t [...]

September 14th, 2021|News|

Teknova Announces Pricing of its Upsized Initial Public Offering

HOLLISTER, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading provider of critical reagents for the development and production of biopharmaceutical products including drug therapies, novel vaccines, and molecular diagnostics, today announced the prici [...]

June 24th, 2021|News|

Precision NanoSystems joins Danaher’s Life Sciences Platform

PORT WASHINGTON, N.Y., June 1, 2021 /PRNewswire/ -- Precision NanoSystems (PNI) has been acquired by Danaher Corporation's Life Sciences platform. PNI is a global leader in technologies and solutions for the development of genetic medicines, including mRNA vaccines and therapeutics. PNI will join Da [...]

June 1st, 2021|News|

Akoya Biosciences Announces Pricing of Initial Public Offering

MARLBOROUGH, Mass., April 15, 2021 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced the pricing of its initial public offering of 6,580,000 shares of its common stock at a price of $20.00 per share, for gross proceeds of $131.6 milli [...]

April 16th, 2021|News|